| Financial Year |
March 31 2022 |
| Monetary Funds |
159,035,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
79,652,000.00 |
| Advances to Suppliers |
13,166,000.00 |
| Other Receivables |
52,830,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
46,745,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,068,000.00 |
| Total Current Assets |
377,496,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
143,308,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
1,489,890,000.00 |
| Under-construction Projects |
75,000,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
150,638,000.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,077,000.00 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,967,870,000.00 |
| Total Assets |
2,345,366,000.00 |
| Short-Term Loans |
1,149,220,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
821,929,000.00 |
| Accounts Received In Advance |
8,863,000.00 |
| Employee Compensation Payable |
7,280,000.00 |
| Taxes Payable |
204,344,000.00 |
| Interest Payable |
238,191,000.00 |
| Dividend Payable |
-- |
| Other payables |
925,811,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
349,919,000.00 |
| Other Current Liabilities |
1,085,000.00 |
| Sub-Total of Current Liabilities |
3,478,770,000.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
454,455,000.00 |
| Deferred Income Tax Liabilities |
2,110,000.00 |
| Other Non-Current Liabilities |
5,756,000.00 |
| Sub-Total of Non-Current Liabilities |
463,635,000.00 |
| Total Liabilities |
3,942,405,000.00 |
| Paid-In Capital(Or Share Stock) |
547,672,000.00 |
| Capital Surplus |
1,910,806,000.00 |
| Surplus Reserve |
246,788,000.00 |
| LESS:Treasury Stock |
20,010,000.00 |
| Undistributed Profits |
-4,163,473,000.00 |
| Minority Stockholder's Interest |
-77,796,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-1,519,243,000.00 |
| Owner's Equity（Stockholder's Equity） |
-1,597,039,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,345,366,000.00 |
